Histogen Inc. (HSTO) stock declined over -14.86% intraday to trade at $1.8476 a share on NASDAQ. The stock opened with a loss of -3.77% at $1.86 and touched an intraday high of $2.63, falling -0.13% against the last close of $1.85. The stock went to a low of $1.61 during the session.
Number of Shares
Cash Flow per Share
Free Float in %
Sales or Revenue4.36 Million
5Y Sales Change5.2%
Fiscal Year Ends2021-12-30
Histogen Inc., a clinical-stage therapeutics company, focuses on developing proprietary hypoxia-generated growth factor technology platform and stem cell-free biologic products. It offers HST-003, a human extracellular matrix, which is in Phase 1/2 clinical trial to treat articular cartilage defects in the knee; HST-004, a cell conditioned media solution to treat spinal disc repair; and Emricasan, an orally active pan-caspase inhibitor for the treatment of COVID-19. The company's preclinical product candidates include CTS-2090 and CTS-2096, which are selective caspase-1 inhibitors targeting inflammasome activation, as well as intervenes in a various inflammation mediated disease. Histogen Inc. was founded in 2007 and is headquartered in San Diego, California.
Histogen Inc. (NASDAQ: HSTO) stock price is $1.8476 as of the last check on Wednesday, August 17. During the trading session, HSTO stock reached the peak price of $2.63 while $1.61 was the lowest point it dropped to.
The NASDAQ listed HSTO is part of Biotechnology industry that operates in the broader Health Care sector. Histogen Inc. , a clinical-stage therapeutics company, focuses on developing proprietary hypoxia-generated growth factor technology platform and stem cell-free biologic products.
Ms. Susan A. Knudson
Exec. VP, CFO & Corp. Sec.
Dr. Martin Latterich Ph.D.
Sr. VP of Technical Operations
Dr. Martin Latterich Ph.D.
Sr. VP of Research
Dr. Steven J. Mento Ph.D.
Exec. Chairman, Interim Pres & CEO
HSTO stock traded closed the last session at $2.17, which is -$0.3224 or -14.857142857142858% lower than its previous close of $1.85. HSTO's current trading price is 21.23% lower than its 52-week high of $18.4 where as its distance from 52-week low of 1.79% is -88.21%.
Number of HSTO employees currently stands at -. HSTO operates from 10655 Sorrento Valley Road, Suite 200, San Diego, CA 92121, United States.
Official Webiste of $HSTO is: https://www.histogen.com
HSTO stock volume for the day was 569,475 shares while in the previous session number of HSTO shares traded was 5,224,091 . The average number of HSTO shares traded daily for last 3 months was 573.55 Thousands.
The percentage change in HSTO stock occurred in the recent session was -14.857142857142858% while the dollar amount for the price change in HSTO stock was -$0.3224.
In the recent session, the day high for HSTO stock was $2.63 while the low for HSTO stock touched on the day was $1.61.
The market value of HSTO currently stands at 5.73 Million with its latest stock price at $1.8476 and 2.5 Million of its shares outstanding.